Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America
Carlos A. Castañeda(Instituto Nacional de Enfermedades Neoplásicas), Julio E. Abugattas(City of Hope), José M. Cotrina(Instituto Nacional de Enfermedades Neoplásicas), Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Luis Cano(Instituto Nacional de Enfermedades Neoplásicas), Renato Galvez(Instituto Nacional de Enfermedades Neoplásicas), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Henry Gómez(National Cancer Center), Valeria Villegas(Universidad Peruana Cayetano Heredia), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Gabriela Calderón(The University of Texas MD Anderson Cancer Center), Joselyn Sanchez(Instituto Nacional de Enfermedades Neoplásicas), Miguel De la Cruz(The University of Texas MD Anderson Cancer Center), Jorge Dunstan(The University of Texas MD Anderson Cancer Center)
Cited by 58
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483